We are an international biotech company committed to improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies, and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, we have formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO®) antibody medicines. We are united by our core values: a passion for innovation, determination, integrity, and working as one team and respecting each other. When you work at Genmab you'll be part of a warm, fun, dynamic community seeking out and embracing the opportunity to build new and bold futures within a rapidly growing biotechnology company. Genmab is a place where you can be authentically you; you are empowered to innovate, build solutions and execute; you feel cared for and supported. In its totality, this makes working at Genmab an extra[not]ordinaryTM experience. Established in 1999, we are headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S., and Tokyo, Japan. For more information, please visit Genmab.com. Disclaimer: http://bit.ly/GENDisclaimer
View Top Employees from GenmabWebsite | http://www.genmab.com |
Ticker | GEN |
Revenue | $5.37 billion |
Employees | 2,339 (1,954 on RocketReach) |
Founded | 1999 |
Address | 43 Kalvebod Brygge, København V, Capital Region 1560, DK |
Phone | (457) 020-2728 |
Fax | (457) 020-2729 |
Technologies |
JavaScript,
HTML,
PHP
+68 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Health Care, Medical |
Web Rank | 1 Million |
Keywords | Biotechnology, Translational Research |
Competitors | Avanir Pharmaceuticals, MacroGenics, Inc., MorphoSys, Nascent Biotech, Inc., Seagen |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 325413 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 5417 Companies, NAICS Code 3254 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 54 Companies |
Looking for a particular Genmab employee's phone or email?
The Genmab annual revenue was $5.37 billion in 2024.
Julie Blaedel is the Vice President Global Medical Affairs of Genmab.
1,954 people are employed at Genmab.
Genmab is based in København V, Capital Region.
The NAICS codes for Genmab are [54171, 325413, 325, 32, 5417, 3254, 541713, 541, 32541, 54].
The SIC codes for Genmab are [873, 87].